Advertisement
Screener

908 DEVICES INC. (MASS) EBITDA

908 DEVICES INC. (MASS) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$11.45M*; Operating income -$12.81M; Depreciation and amortization $1.36M*.
  • 2026-03-31: Basis Reported; EBITDA -$11.75M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $4.2M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$15.23M*; Operating income -$16.32M; Depreciation and amortization $1.09M*.

Complete source-backed ebitda history.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$11.45M*-$12.81M$1.36M*$16.07M-71.22%*$162.00K*$3.17M*(m)$3.60M$11.11M-$54.00K
2026-03-31Reported-$11.75M(m)(m)(m)-87.77%$40.00K$1.21M(m)$3.47M$9.91M(m)
2025-12-31Reported$4.2M(m)(m)(m)24.18%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$15.23M*-$16.32M$1.09M*$14.01M-108.77%*$680.00K*-$4.20M*(m)$3.84M$9.13M$29.00K
2025-06-30Reported-$14.19M*-$15.16M$972.00K*$13.04M-108.85%*$122.00K*-$5.78M*(m)$4.41M$10.34M$71.00K
2025-03-31Reported-$9.74M(m)(m)(m)-82.66%$159.00K-$15.02M(m)$3.83M$10.24M(m)
2024-12-31Reported-$15.31M(m)(m)(m)-106.76%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$23.08M*-$24.49M$1.41M*$14.52M-158.97%*$156.00K*-$5.61M*(m)$4.21M$9.69M-$72.00K
2024-06-30Reported-$8.04M*-$8.54M$504.00K*$11.46M-70.10%*-$647.00K*-$13.04M*(m)$3.59M$11.11M-$69.00K
2024-03-31Reported-$6.28M(m)(m)(m)-84.65%$903.00K-$9.36M(m)$3.29M$8.21M-$70.00K
2023-12-31Reported-$9.31M(m)(m)(m)-64.86%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$8.35M*-$9.09M$740.00K*$14.30M-58.40%*$207.00K*-$4.60M*(m)$5.54M$11.32M-$87.00K
2023-06-30Reported-$10.33M*-$10.94M$605.00K*$12.09M-85.45%*$320.00K*-$7.88M*(m)$5.53M$11.21M-$71.00K
2023-03-31Reported-$12.38M(m)(m)(m)-130.53%$1.19M-$10.65M(m)$5.40M$12.00M(m)
2022-12-31Reported-$9.76M(m)(m)(m)-83.84%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$6.70M*-$7.15M$459.00K*$15.80M-42.38%*$744.00K*-$4.94M*(m)$4.67M$11.83M(m)
2022-06-30Reported-$8.06M*-$8.37M$311.00K*$11.11M-72.56%*$72.00K*-$10.41M*(m)$4.29M$10.71M(m)
2022-03-31Reported-$9.25M(m)(m)(m)-111.41%$617.00K-$466.00K(m)$3.90M$9.74M(m)
2021-12-31Reported-$3.24M(m)(m)(m)-20.45%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$5.01M*-$5.28M$261.00K*$12.54M-39.98%*$58.00K*-$2.92M*(m)$3.30M$8.79M(m)
2021-06-30Reported-$7.22M*-$7.46M$238.00K*$8.28M-87.19%*$616.00K*-$7.30M*(m)$3.06M$8.78M(m)
2021-03-31Reported-$5.67M(m)(m)(m)-102.35%$9.00K-$9.63M(m)$2.96M$5.75M(m)
2020-12-31Reported-$3.67M(m)(m)(m)-64.11%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$1.09M*-$1.29M$201.00K*$6.05M-18.06%*-$175.00K*$8.20M*(m)$1.95M$3.18M(m)
2020-06-30Reported$2.33M*$2.13M$204.00K*$11.13M20.96%*$93.00K*-$3.23M*(m)$1.85M$2.44M(m)
2020-03-31Reported-$2.56M(m)(m)(m)-63.96%$91.00K-$3.17M(m)$2.16M$2.71M(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$34.96M(m)(m)(m)-62.20%$955.00K-$23.69M(m)$15.57M$38.53M-$66.00K
2024-12-31Reported-$52.71M(m)(m)(m)-110.40%$602.00K-$30.25M(m)$14.99M$39.46M-$282.00K
2023-12-31Reported-$40.37M(m)(m)(m)-80.38%$2.04M-$25.06M(m)$21.90M$46.07M-$211.00K
2022-12-31Reported-$33.77M(m)(m)(m)-72.07%$2.04M-$20.93M(m)$17.53M$43.88M$0.00
2021-12-31Reported-$21.14M(m)(m)(m)-50.10%$737.00K-$29.08M(m)$13.07M$32.23M(m)
2020-12-31Reported-$4.98M(m)(m)(m)-18.53%$9.00K$4.13M(m)$8.23M$12.50M(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B